
Crinetics Pharmaceuticals
Novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers.
HQ location
San Diego, United States
Website
Launch date
Employees
Market cap
$2.9b
Enterprise value
$1.7b
Share price
$30.65 CRNX
Recent deals
Authorizing premium user...